Cadrenal Therapeutics logo

Cadrenal Therapeutics

CVKD | NASDAQ
Chart Builder DCF Calculator
$1.40
-$0.11 (-7.28%)
At close: Nov 16, 2026, 4:00 PM ET
$1.57
+$0.17 (+12.39%)
After-hours: Nov 16, 2026, 7:42 PM ET
-7.28%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
31.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #749/1021 (Top 73%)

Key Statistics

Market Data

Market Cap $4.99M
1D Range
1.39 1.54
52W Range
0.87 12.29

Valuation (TTM)

PE -0.29
PB 1.22
EV/EBITDA -0.23

Valuation (NTM)

Forward PE N/A
Forward PEG 0.01
Price Target $32.00
Loading financial charts...

Profile

Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise primarily engaged in clinical development. The company's core focus is the advancement of Tecarfarin, a novel therapeutic agent t...

Sector Healthcare
Industry Biotechnology
Employees 5
IPO Date Jan 20, 2023
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$32.00
Upside
+2185.71%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.